Meeker David P (CIK 1385155) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-22). Recent activity: Buy KARD (20,706 shares), Buy RYTM (68,713 shares), Sell RYTM (31,522 shares), Buy RYTM (43,620 shares), Sell RYTM (43,346 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | Kardigan, Inc. (KARD) | Director | Buy | 20,706 | $0 |
| 2026-02-03 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Buy | 68,713 | $0 |
| 2026-02-03 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Sell | 31,522 | $3.4M |
| 2025-06-05 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Buy | 43,620 | $200,216 |
| 2025-06-05 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Sell | 43,346 | $2.8M |
| 2025-06-05 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Sell | 274 | $17,974 |
| 2025-02-19 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Buy | 21,250 | $0 |
| 2025-02-19 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Sell | 9,896 | $566,249 |
| 2025-02-04 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Buy | 14,125 | $0 |
| 2025-02-04 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Sell | 4,278 | $254,242 |
Source: SEC Form 4 filings · as of 2026-06-22